Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Wellgistics Health (WGRX) Common Equity (2024 - 2025)

Wellgistics Health's Common Equity history spans 2 years, with the latest figure at -$12.4 million for Q4 2025.

  • For the quarter ending Q4 2025, Common Equity fell 284.84% year-over-year to -$12.4 million, compared with a TTM value of -$12.4 million through Dec 2025, down 284.84%, and an annual FY2025 reading of -$12.4 million, down 284.84% over the prior year.
  • Common Equity for Q4 2025 was -$12.4 million at Wellgistics Health, down from $6.8 million in the prior quarter.
  • The five-year high for Common Equity was $10.0 million in Q3 2024, with the low at -$12.4 million in Q4 2025.